Diagnosis and management of sarcopenia
Open Access
- 10 July 2024
- journal article
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 67 (7) , 461-466
Abstract
Background: Sarcopenia refers to the progressive and generalized loss of skeletal muscle mass, strength, and function and is associated with falls, fractures, hospitalization, and even mortality. Owing to rapid population aging, the prevalence of sarcopenia is expected to increase, and this condition is increasingly gaining attention as an important topic in research and clinical settings. This review focuses on the diagnosis, pathophysiology, and management of sarcopenia.Current Concepts: Diagnosis of sarcopenia can be confirmed based on low muscle mass accompanied by low muscle strength, or low physical performance. The European Working Group on Sarcopenia in Older People and the Asian Working Group for Sarcopenia guidelines are commonly used in clinical practice. Intrinsic factors associated with skeletal muscles, such as inflammation, anabolic resistance, mitochondria, and neuromuscular junctions, combined with extrinsic factors associated with the systemic environment, including decreased endocrine function, malnutrition, and immobilization all play a role in impaired muscle anabolism, muscle atrophy, and weakness. Currently, the Food and Drug Administration has not approved any specific medications for treatment of sarcopenia. Therefore, non-pharmacological interventions such as aerobic, resistance, and combined exercise and appropriate nutrition (protein and essential amino acids) are important for prevention and treatment of sarcopenia.Discussion and Conclusion: Sarcopenia is a manageable target for improvement of overall health outcomes. Exercise and nutrition are essential components of nonpharmacological management of sarcopenia. Future studies are needed to identify early diagnostic biomarkers and pharmacologic targets and to develop consistent pre-emptive management strategies and sensitive measures to predict effectiveness of sarcopenia management and treatment response.Keywords
This publication has 31 references indexed in Scilit:
- Sarcopenia in Korean Community-Dwelling Adults Aged 70 Years and Older: Application of Screening and Diagnostic Tools From the Asian Working Group for Sarcopenia 2019 UpdateJournal of the American Medical Directors Association, 2020
- Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and TreatmentJournal of the American Medical Directors Association, 2020
- Sarcopenia: revised European consensus on definition and diagnosisAge and Ageing, 2019
- Protein supplementation improves muscle mass and physical performance in undernourished prefrail and frail elderly subjects: a randomized, double-blind, placebo-controlled trialThe American Journal of Clinical Nutrition, 2018
- Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle functionJournal of Cachexia, Sarcopenia and Muscle, 2016
- Validation of the SarQoL®, a specific health‐related quality of life questionnaire for SarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2016
- Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and olderOsteoporosis International, 2015
- Sarcopenia in Asia: Consensus Report of the Asian Working Group for SarcopeniaJournal of the American Medical Directors Association, 2014
- Anabolic Resistance of Muscle Protein Synthesis with AgingExercise and Sport Sciences Reviews, 2013
- Role and potential mechanisms of anabolic resistance in sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2012